Literature DB >> 27177755

Burkholderia cepacia complex in Serbian patients with cystic fibrosis: prevalence and molecular epidemiology.

Z V Vasiljevic1, K Novovic2, M Kojic2, P Minic3,4, A Sovtic3,4, S Djukic5, B Jovcic2,6.   

Abstract

The Burkholderia cepacia complex (Bcc) organisms remain significant pathogens in patients with cystic fibrosis (CF). This study was performed to evaluate the prevalence, epidemiological characteristics, and presence of molecular markers associated with virulence and transmissibility of the Bcc strains in the National CF Centre in Belgrade, Serbia. The Bcc isolates collected during the four-year study period (2010-2013) were further examined by 16 s rRNA gene, pulsed-field gel electrophoresis of genomic DNA, multilocus sequence typing analysis, and phylogenetic analysis based on concatenated sequence of seven alleles. Fifty out of 184 patients (27.2 %) were colonized with two Bcc species, B. cenocepacia (n = 49) and B. stabilis (n = 1). Thirty-four patients (18.5 %) had chronic colonization. Typing methods revealed a high level of similarity among Bcc isolates, indicating a person-to-person transmission or acquisition from a common source. New sequence types (STs) were identified, and none of the STs with an international distribution were found. One centre-specific ST, B. cenocepacia ST856, was highly dominant and shared by 48/50 (96 %) patients colonized by Bcc. This clone was characterized by PCR positivity for both the B. cepacia epidemic strain marker and cable pilin, and showed close genetic relatedness to the epidemic strain CZ1 (ST32). These results indicate that the impact of Bcc on airway colonization in the Serbian CF population is high and virtually exclusively limited to a single clone of B. cenocepacia. The presence of a highly transmissible clone and probable patient-to-patient spread was observed.

Entities:  

Mesh:

Year:  2016        PMID: 27177755     DOI: 10.1007/s10096-016-2662-4

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  32 in total

Review 1.  Classification and identification of the Burkholderia cepacia complex: Past, present and future.

Authors:  Peter Vandamme; Peter Dawyndt
Journal:  Syst Appl Microbiol       Date:  2011-01-22       Impact factor: 4.022

2.  Infection prevention and control guideline for cystic fibrosis: 2013 update.

Authors:  Lisa Saiman; Jane D Siegel; John J LiPuma; Rebekah F Brown; Elizabeth A Bryson; Mary Jo Chambers; Veronica S Downer; Jill Fliege; Leslie A Hazle; Manu Jain; Bruce C Marshall; Catherine O'Malley; Suzanne R Pattee; Gail Potter-Bynoe; Siobhan Reid; Karen A Robinson; Kathryn A Sabadosa; H Joel Schmidt; Elizabeth Tullis; Jennifer Webber; David J Weber
Journal:  Infect Control Hosp Epidemiol       Date:  2014-07-01       Impact factor: 3.254

3.  Burkholderia cepacia complex infection in Italian patients with cystic fibrosis: prevalence, epidemiology, and genomovar status.

Authors:  A Agodi; E Mahenthiralingam; M Barchitta; V Gianninò; A Sciacca; S Stefani
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

Review 4.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

Review 5.  The changing microbial epidemiology in cystic fibrosis.

Authors:  John J Lipuma
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

6.  Sensitivity of the Burkholderia cepacia complex and Pseudomonas aeruginosa to transducing bacteriophages.

Authors:  S Nzula; P Vandamme; J R Govan
Journal:  FEMS Immunol Med Microbiol       Date:  2000-08

7.  Widespread clone of Burkholderia cenocepacia in cystic fibrosis patients in the Czech Republic.

Authors:  Pavel Drevinek; Sarka Vosahlikova; Ondrej Cinek; Vera Vavrova; Jana Bartosova; Petr Pohunek; Eshwar Mahenthiralingam
Journal:  J Med Microbiol       Date:  2005-07       Impact factor: 2.472

8.  Novel diagnostic PCR assay for Burkholderia cenocepacia epidemic strain ST32 and its utility in monitoring infection in cystic fibrosis patients.

Authors:  Klara Dedeckova; Lucie Kalferstova; Hynek Strnad; Jolana Vavrova; Pavel Drevinek
Journal:  J Cyst Fibros       Date:  2013-01-11       Impact factor: 5.482

9.  Epidemiology and molecular characterization of a clone of Burkholderia cenocepacia responsible for nosocomial pulmonary tract infections in a French intensive care unit.

Authors:  Arnault Graindorge; Aymeric Menard; Manuelle Neto; Claude Bouvet; Roger Miollan; Sandrine Gaillard; Henri de Montclos; Frédéric Laurent; Benoit Cournoyer
Journal:  Diagn Microbiol Infect Dis       Date:  2009-08-27       Impact factor: 2.803

10.  BIGSdb: Scalable analysis of bacterial genome variation at the population level.

Authors:  Keith A Jolley; Martin C J Maiden
Journal:  BMC Bioinformatics       Date:  2010-12-10       Impact factor: 3.169

View more
  5 in total

1.  Clinical and microbiological profile of chronic Burkholderia cepacia complex infections in a cystic fibrosis reference hospital in Brazil.

Authors:  C P da Costa Capizzani; N C Caçador; L A G M M Torres; L Tonani; P Vandamme; A L da Costa Darini
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-08-24       Impact factor: 3.267

2.  C-protein α-antigen modulates the lantibiotic thusin resistance in Streptococcus agalactiae.

Authors:  Nemanja Mirkovic; Mina Obradovic; Paula M O'Connor; Brankica Filipic; Branko Jovcic; Paul D Cotter; Milan Kojic
Journal:  Antonie Van Leeuwenhoek       Date:  2021-07-28       Impact factor: 2.271

3.  What matters in chronic Burkholderia cenocepacia infection in cystic fibrosis: Insights from comparative genomics.

Authors:  Jaroslav Nunvar; Vaclav Capek; Karel Fiser; Libor Fila; Pavel Drevinek
Journal:  PLoS Pathog       Date:  2017-12-11       Impact factor: 6.823

4.  Virulence traits associated with Burkholderia cenocepacia ST856 epidemic strain isolated from cystic fibrosis patients.

Authors:  Milka Malešević; Zorica Vasiljević; Aleksandar Sovtić; Brankica Filipić; Katarina Novović; Milan Kojić; Branko Jovčić
Journal:  Antimicrob Resist Infect Control       Date:  2017-06-06       Impact factor: 4.887

5.  A practical molecular identification of nonfermenting Gram-negative bacteria from cystic fibrosis.

Authors:  Carolina Paulino da Costa Capizzani; Natália Candido Caçador; Elizabeth Andrade Marques; Carlos Emílio Levy; Ludmilla Tonani; Lidia Alice Gomes Monteiro Marin Torres; Ana Lúcia da Costa Darini
Journal:  Braz J Microbiol       Date:  2017-11-04       Impact factor: 2.476

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.